The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Trident Lifeline Ltd
Trident Texofab Ltd. Press Release Apr 01 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Trident Texofab
- Trident Texofab Ltd. Press Release Mar 29 2025
- Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
- Trident Texofab Ltd. Press Release Mar 26 2025
- Board Meeting Outcome for Separate Meeting Of Independent Directors
- Trident Texofab Ltd. Press Release Mar 22 2025
Later from Trident Texofab
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Trident Texofab Ltd. Press Release Apr 11 2025
- Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held May 12, 2025
- Outcome Of Board Meeting Held On May 12, 2025
- Announcement under Regulation 30 (LODR)-Conversion of Securities
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab